Literature DB >> 7615194

Collagenous colitis and fecal stream diversion.

G Järnerot1, C Tysk, J Bohr, S Eriksson.   

Abstract

BACKGROUND & AIMS: The cause of collagenous colitis is unknown. Data on treatment are sparse, and surgical therapy has not been reported. This study reports results of surgical therapy for collagenous colitis.
METHODS: Nine women with unresponsive collagenous colitis underwent surgery. An ileostomy was performed as the first procedure in 8 patients, and a sigmoidostomy using the Hartmann procedure was performed in 1 patient.
RESULTS: Preoperatively, all patients had severe diarrhea, and the median thickness of the subepithelial collagenous layer was 20 microns (range, 10-40 microns). Postoperatively, diarrhea ceased in all patients, and the collagen layer was reduced to 2 microns (range, 0-10 microns). Clinical symptoms and the abnormal collagen layer recurred after restoration of intestinal continuity. After the Hartmann procedure, the collagen layer remained abnormally thickened up to 30 microns in the proximal colon but was normalized in the excluded rectosigmoid colon. One year later, the sigmoidostomy was replaced by a split ileostomy; at follow-up, the collagen layer was normal in the whole colon.
CONCLUSIONS: Fecal stream diversion induced clinical and histopathologic remission in collagenous colitis. After closure of the ostomy, clinical symptoms and the abnormal collagen layer recurred. The findings strongly indicate that a noxious luminal factor is of pathogenetic importance. In older patients with medically resistant disease, a split ileostomy may be the therapeutic procedure of choice.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7615194     DOI: 10.1016/0016-5085(95)90332-1

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  64 in total

1.  Collagenous colitis and rheumatology.

Authors:  F A Wollheim
Journal:  Curr Rheumatol Rep       Date:  2000-06       Impact factor: 4.592

2.  Lymphocytic and Collagenous Colitis.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-06

3.  Lymphocytic and Collagenous Colitis: Medical Management.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-04

4.  Collagenous colitis associated with Clostridium difficile: a cause effect?

Authors:  Tolga Erim; Waleed M Alazmi; Colm J O'Loughlin; Jamie S Barkin
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

Review 5.  Lymphocytic and collagenous colitis: an overview of so-called microscopic colitis.

Authors:  Runjan Chetty; Dhirendra Govender
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-21       Impact factor: 46.802

Review 6.  Biopsy interpretation of colonic biopsies when inflammatory bowel disease is excluded.

Authors:  Tze S Khor; Hiroshi Fujita; Koji Nagata; Michio Shimizu; Gregory Y Lauwers
Journal:  J Gastroenterol       Date:  2012-02-10       Impact factor: 7.527

7.  Microscopic colitis: a retrospective study of clinical presentation in 53 patients.

Authors:  Zsolt Barta; Gabriella Mekkel; István Csípo; László Tóth; Szabolcs Szakáll; Gábor-G Szabó; Gyula Bakó; Gyula Szegedi; Margit Zeher
Journal:  World J Gastroenterol       Date:  2005-03-07       Impact factor: 5.742

8.  Boswellia serrata extract for the treatment of collagenous colitis. A double-blind, randomized, placebo-controlled, multicenter trial.

Authors:  Ahmed Madisch; Stephan Miehlke; Otto Eichele; Jenny Mrwa; Birgit Bethke; Eberhard Kuhlisch; Elke Bästlein; Georg Wilhelms; Andrea Morgner; Bernd Wigginghaus; Manfred Stolte
Journal:  Int J Colorectal Dis       Date:  2007-09-02       Impact factor: 2.571

9.  Activation of nuclear factor kappaB in colonic mucosa from patients with collagenous and ulcerative colitis.

Authors:  L Andresen; V L Jørgensen; A Perner; A Hansen; J Eugen-Olsen; J Rask-Madsen
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

10.  Lymphocytic colitis: clinical presentation and long term course.

Authors:  B Mullhaupt; U Güller; M Anabitarte; R Güller; M Fried
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.